Contraception

1

Early medical abortion without prior ultrasound

Raymond, Elizabeth G., Bracken, Hillary

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 125 KB

english, 2015

2

Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion

Dunn, Sheila, Panjwani, Dilzayn, Gupta, Melini, Meaney, Christopher, Morgan, Rebecca, Feuerstein, Erika

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 222 KB

english, 2015

3

Reaching women where they are: eliminating the initial in-person medical abortion visit

Raymond, Elizabeth G., Grossman, Daniel, Wiebe, Ellen, Winikoff, Beverly

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 149 KB

english, 2015

4

Induction of fetal demise before pregnancy termination: practices of family planning providers

Denny, Colleen C., Baron, Michele B., Lederle, Lauren, Drey, Eleanor A., Kerns, Jennifer L.

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 222 KB

english, 2015

5

A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2

Beksinska, Mags, Greener, Ross, Kleinschmidt, Immo, Pillay, Lavanya, Maphumulo, Virginia, Smit, Jennifer

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 388 KB

english, 2015

6

If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion

Gold, Marji, Chong, Erica

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 148 KB

english, 2015

7

The impact of psychiatric history on women's pre- and postabortion experiences

van Ditzhuijzen, Jenneke, ten Have, Margreet, de Graaf, Ron, van Nijnatten, Carolus H.C.J., Vollebergh, Wilma A.M.

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 242 KB

english, 2015

8

Authors' reply: Hormonal contraceptives and HIV: Hazards of pronouncing “negative” studies with low power

Wall, Kristin M., Kilembe, William, Vwalika, Bellington, Haddad, Lisa, Allen, Susan

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 98 KB

english, 2015

9

Mifepristone by prescription: a dream in the United States but reality in Australia

Grossman, Daniel, Goldstone, Philip

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 297 KB

english, 2015

10

Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data

Cleland, Kelly, Smith, Nicole

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 133 KB

english, 2015

11

Mifepristone label laws and trends in use: recent experiences in four US states

Sheldon, Wendy R., Winikoff, Beverly

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 223 KB

english, 2015

12

Fifteen years: looking back and looking forward

Winikoff, Beverly, Westhoff, Carolyn

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 93 KB

english, 2015

13

Off-label indications for mifepristone in gynecology and obstetrics

Dzuba, Ilana G., Grossman, Daniel, Schreiber, Courtney A.

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 143 KB

english, 2015

14

From qualified physician to licensed health care professional: the time has come to change mifepristone's label

Foster, Angel M., Jackson, Courtney B., LaRoche, Kathryn J., Simmonds, Katherine, Taylor, Diana

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 139 KB

english, 2015

15

Hormonal contraceptives and HIV: hazards of pronouncing “negative” studies with low power

Gollub, Erica L.

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 92 KB

english, 2015

16

Editorial Board

Journal:

Contraception

Year:

2015

Language:

english

File:

PDF, 146 KB

english, 2015

17

Volume 92; Issue 3

Early medical abortion without prior ultrasound

Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion

Reaching women where they are: eliminating the initial in-person medical abortion visit

Induction of fetal demise before pregnancy termination: practices of family planning providers

A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2

If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion

The impact of psychiatric history on women's pre- and postabortion experiences

Authors' reply: Hormonal contraceptives and HIV: Hazards of pronouncing “negative” studies with low power

Mifepristone by prescription: a dream in the United States but reality in Australia

Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data

Mifepristone label laws and trends in use: recent experiences in four US states

Fifteen years: looking back and looking forward

Off-label indications for mifepristone in gynecology and obstetrics

From qualified physician to licensed health care professional: the time has come to change mifepristone's label

Hormonal contraceptives and HIV: hazards of pronouncing “negative” studies with low power

Editorial Board

Table of Contents